During the recent session, Core Scientific Inc (NASDAQ:CORZ)’s traded shares were 1.45 million, with the beta value of the company hitting 7.11. At the last check today, the stock’s price was $14.90, reflecting an intraday gain of 2.90% or $0.42. The 52-week high for the CORZ share is $18.63, that puts it down -25.03 from that peak though still a striking 82.48% gain since the share price plummeted to a 52-week low of $2.61. The company’s market capitalization is $4.16B, and the average intraday trading volume over the past 10 days was 9.62 million shares, and the average trade volume was 10.59 million shares over the past three months.
Core Scientific Inc (CORZ) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.23. CORZ has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.03.
Core Scientific Inc (NASDAQ:CORZ) trade information
Core Scientific Inc (CORZ) registered a 2.90% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.90% in intraday trading to $14.90, hitting a weekly high. The stock’s 5-day price performance is 2.76%, and it has moved by -9.26% in 30 days. The short interest in Core Scientific Inc (NASDAQ:CORZ) is 39.46 million shares and it means that shorts have 3.78 day(s) to cover.
The consensus price target of analysts on Wall Street is $16, which implies an increase of 6.87% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $14 and $20 respectively. As a result, CORZ is trading at a discount of -34.23% off the target high and 6.04% off the low.
Core Scientific Inc (CORZ) estimates and forecasts
Statistics show that Core Scientific Inc has underperformed its competitors in share price, compared to the industry in which it operates. Core Scientific Inc (CORZ) shares have gone up 44.80% during the last six months, with a year-to-date growth rate less than the industry average at -2,729.41% against 8.60. In the rating firms’ projections, revenue will increase 1.75% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 98.37M as predicted by 10 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to 112.16M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 141.93M and 179.29M respectively. In this case, analysts expect current quarter sales to shrink by -30.69% and then drop by -37.44% in the coming quarter.
While earnings are projected to return -514.49% in 2025.
CORZ Dividends
Core Scientific Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Core Scientific Inc (NASDAQ:CORZ)’s Major holders
Core Scientific Inc insiders own 10.89% of total outstanding shares while institutional holders control 67.67%, with the float percentage being 75.94%.
